Genomic and bioinformatics analyses of HAdV-4vac and HAdV-7vac, two human adenovirus (HAdV) strains that constituted original prophylaxis against HAdV-related acute respiratory disease, a reemerging epidemic disease

Journal of Clinical Microbiology

Volumn 43, Issue 7, 2005, Pages 3083-3094

  Purkayastha, Anjan ^a,b,c   Su, Jing ^a,b,c   McGraw, John ^c,d   Ditty, Susan E ^c,d,f   Hadfield, Ted L ^c,d,f   Seto, Jason ^a   Russell, Kevin L ^c,e   Tibbetts, Clark ^b,c   Seto, Donald ^a,b,c  

^a GEORGE MASON UNIVERSITY   (United States)

^b HQ USAF Surgeon General Office   (United States)

^c Epidem Outbreak Survlnc Consortium   (United States)

^d ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^e NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^f MIDWEST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ACUTE RESPIRATORY TRACT DISEASE; ARTICLE; BASE MISPAIRING; BIOINFORMATICS; FORENSIC MEDICINE; GENBANK; GENE DELETION; GENE INSERTION; GENETIC RECOMBINATION; GENOME ANALYSIS; GENOMICS; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 4; HUMAN ADENOVIRUS 7; HUMAN CELL; INVERTED TERMINAL REPEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE; VIRUS GENOME; VIRUS STRAIN; VIRUS VIRULENCE;

ACUTE DISEASE; ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; AMINO ACID SEQUENCE; BASE SEQUENCE; CAPSID PROTEINS; COMMUNICABLE DISEASES, EMERGING; COMPUTATIONAL BIOLOGY; GENOME, VIRAL; GENOMICS; HUMANS; MOLECULAR SEQUENCE DATA; RESPIRATORY TRACT INFECTIONS; SEQUENCE ANALYSIS, DNA; VIRAL VACCINES;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

EID: 22144452915     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.7.3083-3094.2005     Document Type: Article

References (57)

1. Ada, G. 1997. Overview of vaccines. Mol. Biotechnol. 8:123-134.
2. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
3. Barraza, E. M., S. L. Ludwig, J. C. Gaydos, and J. F. Brundage. 1999. Reemergence of adenovirus type 4 acute respiratory disease in military trainees: report of an outbreak during a lapse in vaccination. J. Infect. Dis. 179:1531-1533.
4. Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520-1523.
5. Berriman, M., and K. Rutherford. 2003. Viewing and annotating sequence data with Artemis. Brief Bioinform. 4:124-132.
6. Besemer, J., and M. Borodovsky. 1999. Heuristic approach to deriving models for gene finding. Nucleic Acids Res. 27:3911-3920.
7. Blasiole, D. A., D. Metzgar, L. T. Daum, M. A. K. Ryan, J. Wu, C. Wills, C. T. Le, N. E. Freed, C. J. Hansen, G. C. Gray, and K. L. Russell. 2004. Molecular analysis of adenovirus isolates from vaccinated and unvaccinated young adults. J. Clin. Microbiol. 42:1685-1693.
8. Buescher, E. L. 1967. Respiratory disease and the adenoviruses. Med. Clin. N. Am. 51:769-779.
9. Cockle, P. J., S. V. Gordon, A. Lalvani, B. M. Buddle, R. G. Hewinson, and H. M. Vordermeier. 2002. Identification of novel Mycobacterium tuberculosis antigens with potential as diagnostic reagents or subunit vaccine candidates by comparative genomics. Infect. Immun. 70:6996-7003.
10. Cooper, R. J., A. S. Bailey, R. Killough, and S. J. Richmond. 1993. Genome analysis of adenovirus 4 isolated over a six year period. J. Med. Virol. 39:62-66.
11. Couch, R. B., R. M. Chanock, T. R. Cate, D. J. Lang, V. Knight, and R. J. Huebner. 1963. Immunization with types 4 and 7 adenovirus by selective infection of the intestinal tract. Am. Rev. Respir. Dis. 88(Suppl.):394-403.
12. Crawford-Miksza, L., and D. P. Schnurr. 1996. Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues. J. Virol. 70:1836-1844.
13. Crawford-Miksza, L. K., R. N. Nang, and D. P. Schnurr. 1999. Strain variation in adenovirus serotypes 4 and 7a causing acute respiratory disease. J. Clin. Microbiol. 37:1107-1112.
14. Dan, A., P. Elo, B. Harrach, Z. Zadori, and M. Benko. 2001. Four new inverted terminal repeat sequences from bovine adenoviruses reveal striking differences in the length and content of the ITRs. Virus Genes 22:175-179.
15. Davison, A. J., M. Benko, and B. Harrach. 2003. Genetic content and evolution of adenoviruses. J. Gen. Virol. 84:2895-2908.
16. De Jong, J. C., A. G. Wermenbol, M. W. Verweij-Uijterwaal, K. W. Slaterus, P. Wertheim-Van Dillen, G. J. Van Doornum, S. H. Khoo, and J. C. Hierholzer. 1999. Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively. J. Clin. Microbiol. 37: 3940-3945.
17. Dudding, B. A., S. C. Wagner, J. A. Zeller, J. T. Gmelich, G. R. French, and F. H. Top, Jr. 1972. Fatal pneumonia associated with adenovirus type 7 in three military trainees. N. Engl. J. Med. 286:1289-1292.
18. Erdman, D. D., W. Xu, S. I. Gerber, G. C. Gray, D. Schnurr, A. E. Kajon, and L. J. Anderson. 2002. Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000. Emerg. Infect. Dis. 8:269-277.
19. Gaydos, C. A., and J. C. Gaydos. 1995. Adenovirus vaccines in the U.S. military. Mil. Med. 160:300-304.
20. Graur, D., and W.-H. Li. 2000. Fundamentals of molecular evolution, 2nd ed. Sinauer Associates Inc., Sunderland, Mass.
21. Gray, G. C., P. R. Goswami, M. D. Malasig, A. W. Hawksworth, D. H. Trump, M. A. Ryan, and D. P. Schnurr. 2000. Adult adenovirus infections: loss of orphaned vaccines precipitates military respiratory disease epidemics. Clin. Infect. Dis. 31:663-670.
22. Harris, M. P., and R. T. Hay. 1988. DNA sequences required for the initiation of adenovirus type 4 DNA replication in vitro. J. Mol. Biol. 201:57-67.
23. Hasson, T. B., P. D. Soloway, D. A. Ornelles, W. Doerfler, and T. Shenk. 1989. Adenovirus L1 52- and 55-kilodalton proteins are required for assembly of virions. J. Virol. 63:3612-3621.
24. Hilleman, M. R., R. A. Stallones, R. L. Gauld, M. S. Warfield, and S. A. Anderson. 1956. Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine. Proc. Soc. Exp. Biol. Med. 92:377-383.
25. Hilleman, M. R., and J. H. Werner. 1954. Recovery of new agent from patients with acute respiratory illness. Proc. Soc. Exp. Biol. Med. 85:183-188.
26. Jacobs, S. C., A. J. Davison, S. Carr, A. M. Bennett, R. Phillpotts, and G. W. Wilkinson. 2004. Characterization and manipulation of the human adenovirus 4 genome. J. Gen. Virol. 85:3361-3366.
27. Kajon, A., and G. Wadell. 1994. Genome analysis of South American adenovirus strains of serotype 7 collected over a 7-year period. J. Clin. Microbiol. 32:2321-2323.
28. Kajon, A. E., and G. Wadell. 1992. Characterization of adenovirus genome type 7h: analysis of its relationship to other members of serotype 7. Intervirology 33:86-90.
29. Kajon, A. E., W. Xu, and D. D. Erdman. 2005. Sequence polymorphism in the E3 7.7K ORF of subspecies B1 human adenoviruses. Virus Res. 107:11-19.
30. Kumar, S., K. Tamura, I. B. Jakobsen, and M. Nei. 2001. MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244-1245.
31. Lauer, K. P., I. Llorente, E. Blair, J. Seto, V. Krasnov, A. Purkayastha, S. E. Ditty, T. L. Hadfield, C. Buck, C. Tibbetts, and D. Seto. 2004. Natural variation among human adenoviruses: genome sequence and annotation of human adenovirus serotype 1. J. Gen. Virol. 85:2615-2625.
32. Le, C. T., G. C. Gray, and S. K. Poddar. 2001. A modified rapid method of nucleic acid isolation from suspension of matured virus applied in restriction analysis of DNA from an adenovirus prototype strain and a patient isolate. J. Med. Microbiol. 50:571-574.
33. Lee, S.-G., and P. O. Hung. 1993. Vaccines for control of respiratory disease caused by adenoviruses. Rev. Med. Virol. 3:209-216.
34. Levin, S., J. Dietrich, and J. Guillory. 1967. Fatal nonbacterial pneumonia associated with Adenovirus type 4. Occurrence in an adult. JAMA 201:975-977.
35. Liu, H., J. H. Naismith, and R. T. Hay. 2003. Adenovirus DNA replication, p. 131-164. In W. Doerfler and P. Bohm (ed.), Adenoviruses: model and vectors in virus-host interactions. Springer, Berlin, Germany.
36. Mathews, M. B., and T. Shenk. 1991. Adenovirus virus-associated RNA and translation control. J. Virol. 65:5657-5662.
37. Mul, Y. M., C. P. Verrijzer, and P. C. van der Vliet. 1990. Transcription factors NFI and NFIII/oct-1 function independently, employing different mechanisms to enhance adenovirus DNA replication. J. Virol. 64:5510-5518.
38. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.
39. Purkayastha, A., S. E. Ditty, J. Su, J. McGraw, T. L. Hadfield, C. Tibbetts, and D. Seto. 2005. Genomic and bioinformatics analysis of HAdV-4, a human adenovirus causing acute respiratory disease. Implications for gene therapy and vaccine vector development. J. Virol. 79:2559-2572.
40. Purkayastha, A., J. Su, S. Carlisle, C. Tibbetts, and D. Seto. 2005. Genomic and bioinformatics analysis of HAdV-7, a human adenovirus of species B1 that causes acute respiratory disease: implications for vector development in human gene therapy. Virology 332:114-129.
41. Rowe, W. P., R. J. Huebner, L. K. Gilmore, R. H. Parrot, and T. G. Ward. 1953. Isolation of a cytopathic agent from human adenoids undergoing spontaneous degradation in tissue culture. Proc. Soc. Exp. Biol. Med. 84: 570-573.
42. Rux, J. J., P. R. Kuser, and R. M. Bornett. 2003. Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution X-ray crystallographic, molecular modeling, and sequence-based methods. J. Virol. 77: 9553-9566.
43. Ryan, M., G. Gray, A. Hawksworth, M. Malasig, M. Hudspeth, and S. Poddar. 2000. The Naval Health Research Center Respiratory Disease Laboratory. Mil. Med. 165:32-34.
44. Ryan, M. A. K., G. C. Gray, M. D. Malasig, L. N. Binn, L. V. Asher, D. Cute, S. C. Kehl, B. E. Dunn, and A. J. Yund. 2001. Two fatal cases of adenovirus-related illness in previously healthy young adults-Illinois, 2000. Morb. Mortal. Wkly. Rep. 50:553-555.
45. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
46. San Martin, C., and R. M. Burnett. 2003. Structural studies on adenoviruses, p. 57-94. In W. Doerfler and P. Bohm (ed.), Adenoviruses: model and vectors in virus-host interactions. Springer, Berlin, Germany.
47. Schmitz, H., R. Wigand, and W. Heinrich. 1983. Worldwide epidemiology of human adenovirus infections. Am. J. Epidemiol. 117:455-466.
48. Schwartz, S., Z. Zhang, K. A. Frazer, A. Smit, C. Riemer, J. Bouck, R. Gibbs, R. Hardison, and W. Miller. 2000. PipMaker-a web server for aligning two genomic DNA sequences. Genome. Res. 10:577-586.
49. Sugarman, B., B. M. Hutchins, D. L. McAllister, F. Lu, and B. K. Thomas. 2003. The complete nucleic acid sequence of the adenovirus type 5 reference material (ARM) genome. Bioprocessing 2003(Sept./Oct.):27-32.
50. Takafuji, E. T., J. C. Gaydos, R. G. Allen, and F. H. Top, Jr. 1979. Simultaneous administration of live, enteric-coated adenovirus types 4, 7 and 21 vaccines: safety and immunogenicity. J. Infect. Dis. 140:48-53.
51. Temperley, S. M., and R. T. Hay. 1992. Recognition of the adenovirus type 2 origin of DNA replication by the virally encoded DNA polymerase and preterminal proteins. EMBO J. 11:761-768.
52. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL_X Windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
53. Top, F. H., Jr., E. L. Buescher, W. H. Bancroft, and P. K. Russell. 1971. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J. Infect. Dis. 124:155-160.
54. Top, F. H., Jr., R. A. Grossman, P. J. Bartelloni, H. E. Segal, B. A. Dudding, P. K. Russell, and E. L. Buescher. 1971. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. J. Infect. Dis. 124:148-154.
55. Wickham, T. J., P. Mathias, D. A. Cheresh, and G. R. Nemerow. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
56. Wold, W. S., and L. R. Gooding. 1991. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1-8.
57. Yen, R. F., L. P. Lim, and C. B. Burge. 2001. Computational inference of homologous gene structures in the human genome. Genome Res. 11:803-816.